Massachusetts City Sues Opioid Makers, Distributors - NBC10 Boston

Massachusetts City Sues Opioid Makers, Distributors

Find NBC Boston in your area

Channel 10 on most providers

Channel 15, 60 and 8 Over the Air

    processing...

    NEWSLETTERS

    Taking the Opioid Battle to the Courts

    City of Greenfield, Massachusetts, is joining a class action lawsuit against drug makers. Mayor William Martin and attorney Tom Merrigan explain why they're suing. Click here for more on the lawsuit and click here for more on the law firm.

    (Published Tuesday, Oct. 31, 2017)

    Greenfield filed a federal lawsuit Thursday against several distributors and manufacturers of opioid medications, joining a growing list of municipalities and states seeking to recoup the cost of dealing with the epidemic.

    The city is the first municipality in the state to file such a suit, said Pete Merrigan, of Merrigan Sweeney, the city's law firm. Dozens of states, counties, municipalities and even hospitals across the country have filed similar lawsuits.

    The city, home to 18,000 residents, seeks unspecified damages caused by the opioid epidemic, including the costs of providing medical care and treatment for the addicted.

    "Let's stop kidding ourselves and have them own up to their obligation to be compliant with the law, which would prevent community addiction," Greenfield Mayor William Martin told The Recorder newspaper.

    Toddler Towed With Car, Left in Freezing Lot Overnight

    [NATL] Toddler Towed With Car, Left in Freezing Wisconsin Lot Overnight

    A 4-year-old girl was left alone inside a minivan overnight in a Milwaukee tow lot, authorities said. An impaired driver was pulled over and arrested for operating while intoxicated. Officers removed a 10-month-old child from the vehicle but left the 4-year-old girl, who spent the night in the tow lot where temperatures dropped to 19 degrees.

    (Published Thursday, Nov. 15, 2018)

    The city seeks to "eliminate the hazard to public health and safety" caused by the opioid epidemic and recover money spent "because of defendants' false, deceptive and unfair marketing," according to the suit filed in U.S. District Court in Springfield.

    One of the nearly two dozen defendants is Connecticut-based Purdue Pharma, the developer of OxyContin.

    "We are deeply troubled by the prescription and illicit opioid abuse crisis, and are dedicated to being part of the solution," the company said in a statement. "We vigorously deny these allegations."

    Northwestern District Attorney David Sullivan, the prosecutor whose jurisdiction includes Greenfield, endorsed the lawsuit.

    "Opioid manufacturers and distributors need to be held accountable for their outrageous sales and marketing practices," Sullivan said in a statement.

    The Massachusetts attorney general is part of a multistate coalition investigating whether drug-makers sought to increase profits by misrepresenting the dangers of prescription painkillers and ignoring the public health risks of spiking opioid sales, but a spokeswoman says no lawsuit has been filed.

    Professor Sues Over Transgender Pronoun Rebuke

    [NATL] Professor Sues Over Transgender Pronoun Rebuke

    A Shawnee State University professor is suing officials after receiving a written warning for violating its nondiscrimination policy by not addressing a transgender student using the gender terms preferred by the student. Nicholas Meriwether, a philosophy professor and evangelical Christian, filed a federal lawsuit this month against officials at the university in Portsmouth. 

    (Published Thursday, Nov. 15, 2018)

    The city of Quincy indicated in late October that it intended to sue opioid manufacturers, but a spokesman for Mayor Thomas Koch said no suit had been filed as of Friday.

    Merrigan Sweeney represents several other Massachusetts cities considering lawsuits, Merrigan said.


    Get the latest from NBC Boston anywhere, anytime:

    App

    Download our FREE app for iPhone, iPad and Android. You can also follow us on Facebook, Twitter and Instagram, and sign up for our e-mail newsletters.